These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6689620)

  • 1. [Comparison between the Nd YAG Q-switched laser and the mode-switched type. Preliminary note].
    Peters O; Belgrado G; Verworst F; Pameijer J; Brihaye C
    Bull Soc Belge Ophtalmol; 1983; 207():121-7. PubMed ID: 6689620
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acquired bilateral nevus of ota-like macules (Hori's nevus) with a combination of the 532 nm Q-Switched Nd:YAG laser followed by the 1,064 nm Q-switched Nd:YAG is more effective: prospective study.
    Ee HL; Goh CL; Khoo LS; Chan ES; Ang P
    Dermatol Surg; 2006 Jan; 32(1):34-40. PubMed ID: 16393596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of clinical, microscopic, and ultrastructural changes after treatment with a novel Q-switched Nd:YAG laser.
    Berlin AL; Dudelzak J; Hussain M; Phelps R; Goldberg DJ
    J Cosmet Laser Ther; 2008 Jun; 10(2):76-9. PubMed ID: 18569259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future of the laser in ophthalmology.
    Fankhauser F; Van der Zypen E
    Trans Ophthalmol Soc U K (1962); 1982 Apr; 102 (Pt 1)():159-63. PubMed ID: 6963050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of biophysical properties of skin measured by using non-invasive techniques in the KM mice following 595 nm pulsed dye, 1064 nm Q-Switched Nd:YAG and 1320 nm Nd:YAG laser non-ablative rejuvenation.
    Dang Y; Ren Q; Li W; Yang Q; Zhang J
    Skin Res Technol; 2006 May; 12(2):119-25. PubMed ID: 16626386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters.
    Vandorselaer T; Van De Velde F; Tassignon MJ
    Bull Soc Belge Ophtalmol; 2001; (280):15-9. PubMed ID: 11486460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 532-nm and 1064-nm Q-switched Nd:YAG laser therapy for reduction of pigmentation in macular amyloidosis patches.
    Ostovari N; Mohtasham N; Oadras MS; Malekzad F
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):442-6. PubMed ID: 18363913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the disruptive effect of Q-switched and mode-locked Nd-YAG lasers].
    Dölle W; Duncker G
    Fortschr Ophthalmol; 1986; 83(4):430-2. PubMed ID: 3770612
    [No Abstract]   [Full Text] [Related]  

  • 9. [A universal laser for intraocular treatment].
    Pomerantzeff O; Vallat M; Pankratov MM; Pflibsen KP; Schepens CL
    J Fr Ophtalmol; 1988; 11(12):873-7. PubMed ID: 3253317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience in intraocular surgery with the Meditec OPL3 mode-locked and the LASAG Microruptor II Q-switched Nd-YAG lasers.
    Alpar JJ
    CLAO J; 1985; 11(3):211-8. PubMed ID: 4042310
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases.
    Fusade T
    Br J Dermatol; 2008 Jan; 158(1):84-7. PubMed ID: 17916214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histological responses of congenital melanocytic nevi after single treatment with Q-switched lasers.
    Grevelink JM; van Leeuwen RL; Anderson RR; Byers HR
    Arch Dermatol; 1997 Mar; 133(3):349-53. PubMed ID: 9080896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beam obstruction hazard on Q-switched Nd-YAG ophthalmic lasers: a safety device for the Nanolas laser.
    Moseley H; Richardson W; Dutton GN
    Br J Ophthalmol; 1991 Jul; 75(7):447. PubMed ID: 1854705
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of the anterior segment with Q-switched laser Neodymium YAG].
    Brihaye M; Verworst F; Verlaeken L; Schyns P; Van Looy R
    Bull Soc Belge Ophtalmol; 1982; 199-200():27-30. PubMed ID: 6897814
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of a high-performance laser on the anterior and posterior segments (author's transl)].
    Fankhauser F; Hommer K; Roussel P; van der Zypen E; Steffen J; Chrenkova A
    Klin Monbl Augenheilkd; 1981 Dec; 179(6):428. PubMed ID: 7201041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing treatment parameters for hair removal using a topical carbon-based solution and 1064-nm Q-switched neodymium:YAG laser energy.
    Nanni CA; Alster TS
    Arch Dermatol; 1997 Dec; 133(12):1546-9. PubMed ID: 9420539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for Q-switched and mode-locked Nd: YAG lasers in vitreoretinal pathology.
    Tassignon MJ; Kreissig I; Stempels N; Brihaye M
    Eur J Ophthalmol; 1991; 1(3):123-30. PubMed ID: 1841668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable Q-switched mode-locked Nd3+:LuVO4 laser by Cr4+:YAG crystal.
    Lin JH; Chen HR; Hsu HH; Wei MD; Lin KH; Hsieh WF
    Opt Express; 2008 Oct; 16(21):16538-45. PubMed ID: 18852762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of the pulsed Nd-YAG laser in the vitreous.
    Brown GC; Tasman WS; Benson WE; Scimeca G
    Trans Pa Acad Ophthalmol Otolaryngol; 1985; 37(2):123-7. PubMed ID: 3839326
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of histologic, biochemical, and mechanical properties of murine skin treated with the 1064-nm and 1320-nm Nd:YAG lasers.
    Dang YY; Ren QS; Liu HX; Ma JB; Zhang JS
    Exp Dermatol; 2005 Dec; 14(12):876-82. PubMed ID: 16274454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.